康复器械

Search documents
英科医疗:暂无布局脑机接口或基因测序等领域的计划
Mei Ri Jing Ji Xin Wen· 2025-08-01 05:28
Group 1 - The core strategy of the company is to consolidate its advantages in disposable protective products and rehabilitation equipment, with no current plans to invest in high-tech medical industries such as brain-computer interfaces or gene sequencing [1] - The company will focus on upgrading its core business technology and market expansion, and will fulfill its information disclosure obligations if there are any new business plans in the future [1]
英科医疗:暂无布局脑机接口或基因测序等领域计划
Sou Hu Cai Jing· 2025-08-01 00:54
来源:金融界 金融界8月1日消息,有投资者在互动平台向英科医疗提问:请问公司在保证主业行业地位的前提下,能 否适当投资开发脑机接口或基因测序等高科技医疗产业,实现一体两翼的发展战略。 公司回答表示:尊敬的投资者您好,公司当前战略核心是巩固一次性防护用品及康复器械的主业优势, 暂无布局脑机接口或基因测序等领域的计划。未来将聚焦主业技术升级与市场拓展,若有新业务规划, 会及时履行信息披露义务。感谢您的关注! ...
小切口大文章:南京高淳医疗器械产业园的“创新源”崛起之路
Jiang Nan Shi Bao· 2025-05-15 08:00
Core Insights - Nanjing's Gaochun District has rapidly developed its medical device industry, transforming from a planned area to a national-level foreign trade transformation and upgrading base, with nearly 800 medical device companies now clustered in the region [1][2]. Group 1: Industry Development - In 2018, Gaochun District identified the medical device sector as a key area for development, leading to the establishment of the Nanjing Medical Device Industrial Park, which became a specialized park focused on medical devices in 2020 [2]. - The industrial park covers an area of 7.78 square kilometers and has attracted 800 medical device companies, including 193 production enterprises, with projected revenue of 4.1 billion yuan in 2024, representing a 15% year-on-year growth [2]. Group 2: Innovation and Technology - The rise of the Nanjing Medical Device Industrial Park is driven by innovation, focusing on high-value consumables, in vitro diagnostics, and rehabilitation devices, attracting specialized companies with technological barriers [3]. - Notable companies include Nanjing Youdebang Medical Technology, which has over 50 patents in vascular high-value consumables, and Nanjing Dewen Medical Technology, which leads in tumor minimally invasive ablation with over 100 patents [3]. Group 3: Ecosystem and Support Services - Gaochun District has established a comprehensive service platform to support the medical device industry, including a public service platform that accelerates product market entry by over 30% [4]. - The district encourages the establishment of production support service platforms, including sterilization and waste disposal centers, to provide full lifecycle support for enterprises [4]. Group 4: International Expansion - The industrial park has adopted a market-oriented approach to attract social capital, creating a "park within a park" model, with the launch of the Yunxi Medical Device Industrial Park, which aims to become a benchmark for industrial internet smart parks [6]. - Companies in the park, such as Sruqi Medical and Weikejia, have expanded their products to over 50 countries in Europe, America, and Southeast Asia, further solidifying their international presence [8]. Group 5: Future Vision - The Nanjing Medical Device Industrial Park aims to develop into a specialized medical device industry cluster worth 10 billion yuan, integrating healthcare, medical information, and artificial intelligence to foster new smart healthcare business models [9]. - The competitive landscape of the medical device industry is fundamentally about the competition of innovation ecosystems, with Gaochun focusing on a closed-loop ecosystem of innovation, industry, and service chains to attract global resources [9].
山东将加快推进科技助残
Da Zhong Ri Bao· 2025-05-14 01:10
Core Viewpoint - The Shandong provincial government is accelerating the promotion of technology-assisted support for people with disabilities, focusing on integrating technological innovation with industry innovation to enhance the welfare of disabled individuals [3]. Group 1: Policy Implementation - The provincial government has introduced the first provincial-level special document on technology-assisted support for people with disabilities in response to national directives [3][4]. - The measures consist of five parts, including 15 specific initiatives and 42 tasks, emphasizing application-oriented approaches based on the needs of disabled individuals and elderly people [4]. Group 2: Key Features of the Measures - The measures are characterized by precise positioning, highlighting application orientation and focusing on the significant needs of disabled individuals to accelerate the transformation of technological achievements into productive forces [4]. - The initiative aims to upgrade and resolve bottlenecks in the field of technology-assisted support, emphasizing the role of technology enterprises and high-level research institutions in driving innovation [4]. - A systematic layout is established to create a collaborative mechanism that encompasses demand-driven approaches, technological breakthroughs, achievement transformation, and practical applications [4]. Group 3: Focus Areas for Technological Innovation - The core initiatives include achieving breakthroughs in key technologies and developing assistive products, with a demand-driven approach to identify urgent technological needs in the field [5]. - The provincial government plans to publicly recruit teams for project research on key assistive technology topics for the year 2025 [5]. - Key areas of focus for new strategic and leading technological innovation projects include brain-computer interfaces, artificial intelligence, and rehabilitation devices [5].
75.66亿!鱼跃医疗最新财报
思宇MedTech· 2025-04-27 15:05
正式报名:首届全球心血管大会 | 重磅亮点 合作伙伴征集:2025全球手术机器人大会 2025年4月26日, 鱼跃医疗 发布了2024年年报以及2025一季报。 | | | 2023 年 | | 本年比 | | | | --- | --- | --- | --- | --- | --- | --- | | | | | | 上年增 | 2022 年 | | | | 2024 年 | | | 视 | | | | | | 调整前 | 调整后 | 调整后 | 调整前 | 调整后 | | 营业收入 | 7.565.819.017.28 | 7.971.734.452.47 | 7.971.734.452.47 | -5.09% | 7.101.679.159.74 | 7.101.679.159.74 | | (元) | | | | | | | | 归属于上市 公司股东的 | 1.805.700.655.26 | 2.395.853.276.49 | 2.395.853.276.49 | -24.63% | 1.595.037.435.14 | 1.595.037.435.14 | | 净利润 | | | | | | ...